Clinical manifestations of the 16 leukodystrophy patients carrying AARS2 mutations include cognitive decline, psychiatric symptoms, pyramidal symptoms, extrapyramidal signs, cerebellar symptoms, dystonia, and epilepsy (Table 1). This evidence concerns the gene AARS2 and epilepsy.